tirzepatide in the news is NO longer SHORTAGE. What You Need to Know Eli Lilly's Weight-Loss, Diabetes Drug

Data collected from a randomized, placebo-controlled, double-blind trial of liraglutide 3.0 mg, in which nausea was the most frequent adverse event, showed that greater weight loss was associated with transient nausea and vomiting in participants with obesity but without diabetes [50]

Timing your medication, staying well-hydrated during non-fasting periods, and choosing nutrient-dense foods when you eat will help support your body through fasting and medication effects

When administered under medical supervision, high-dose Vitamin C IV therapy is generally well tolerated

Cross-sectional and Longitudinal Associations Between Tinnitus and Mental Health in a Population-Based Sample of Middle-aged and Elderly Persons